I know that flipper, but as many posters have pointed out if for a failed trial, there would be no rash to get in and present.

The way the company put LL and B in that presentation shows it's unlikely a failed trial, particularly on top of the fact we have had lots of blinded data, and pretty much know how SOC has behaved over the years. All points out to a successful trial.

Other question?

The market via MMs, led by CEDL which has been always on top of the ask for quite a while, has set a perfect stage for Linda Powers.

The losers list will soon be extended from the short to the various bottomfeeders, including those who have a long learning curve, and who practice laws in message boxes, etc.

Buying at this level is a no brainer thanks to Linda's failure to attract a strong financial backer who would have no tolerance to any market manipulation. All Linda's dozens or so existing financiers are just some broken arrows, vulture in nature without enough resources, let alone guts. Bigger can just tweet, besides that not much of open market buying. That's the opportunity Ladies and Gentlemen.

When you see a Form 4 or two, that would be too late for cheap shares.

Again because of that, buying at this level is a no brainer. Manipulation has happened often. It's not because we are trading on OTC but it's because we have not yet secured a strong financial backing. For this reason, thank you all who have tried to contact big wall street sharks.

Whatever and however you think that the prestigious conference would not accept Drs L and B to present P3 DCVax-L results in its plenary session in the form of a late breaker fashion on 1 Sep without having a peek at some significant positive results.

Before a significant financial baker onboard, it's no brainer to buy.

From sharpie510's post above:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158195899

It does seem the company has locked the data or is about to lock the data. Otherwise the unblinded data would not come out of the 13-year old trial like what Les said in the video aired on 8 September:

https://www.biztvclub.com/tv/search/video/6a63a72571be4a60f2ed7d4b91dcdcd8

Listen to 24-30 marks.

So it seems the company may acknowledge DL either via a news release or a filing or by Linda during her attendance the meeting on 12 Sep.

Or it may simply not acknowledge it publicly, and elect to only announce topline data.

But it does seem or is confirmed by Les topline data will be announced this month.

It also does make me wonder why Linda will be presenting on 12 Sep meeting without unblinded to data. Normally she would be quiet during such a special period awaiting topline data/unblind.

In 8k dated 1 Sep, Linda says

"The phased buildout of our Sawston, UK facility and now our acquisition of Flaskworks are major building blocks towards achieving these goals. These steps, along with others in process, have been years in the making to reach fruition at the same time as we are reaching the results of our Phase 3 clinical trial of DCVax-L for Glioblastoma."

Can that statement serve as an update or indication maybe what we expect the next is not DL but Topline data?

plus, the company had talked about what venue and time the company will determine to present findings of the trial in consultation with PI and other experts after the company is unblinded.

Now it seems LL and Bosch will be presenting on 20 Nov, preceded by LP's presence/speaking on 12 Sep.

Is the above also indication that the data has been locked pending public reporting?

I would say either way, ie, the company will report DL or the company will directly report Topline data bypassing DL announcement, is likely.

Honestly, I like this ambiguity since I plan to hold the vast majority of my shares for a long term, and because it irritates traders and shorts.

Bought a little above 50K more shares ranging from 0.628 to 0.635. Thanks.

Seem the price drop again. back to buying

And it seems the whole Dutch Real Estate has been frozen releasing full time of its many lawyers to flood BB/MB

Believe or not, we are about to have the reading of DCVax-L P3 trial for GBM

That is just beginning as the now still conceptual MOA is proven and verified by the trial data

Many doors open for approval of many other solid tumors because of the proven MOA

That's a sure thing. The timing of course is anybody's guess. Definitely not days nor years.

For anyone who has a target price of a few dollars, you will be soon shown the door out.

Bye then

Criminal activities committed yesterday around 10:44am by those who wanted to stop the momentum which has been built up beginning around 2 September.

By implementing that rogue/criminal nature transaction which dropped the share price from 0.60s to 0.005 in a moment, it brutally disrupted the intense momentum in the beginning of the morning trading, preceded by some desperate short selling to bring the price down and hold it at around 0.60s. Sensed they would fail badly they initiated that rogue/criminal transaction.

Big boys including MMs trade stocks using own proprietary algorithms (computerized programs)based on own parameters. In normal time, a strong upsurging momentum would accelerate as the algorithms are all set to detect and execute changes/momentum, and the opposite is true in a downward trend, and in that case, instead of accelerated price increase it would be accelerated price drop.

So it seemed the evil force succeeded yesterday stopping the upsurged price movement by suddenly and brutally changing the conditions in which all these algorithms were working at that moment all the way back to the beginning of the morning, ie, competing with each other for shares which saw prices increasingly accelerated.

I expect after SEC takes action to get the bottom of it, we will be able to find out who are behind that rogue/criminal transaction, and how SEC penalize those responsible.

Flipper is right. Without that transaction, we might see $1 yesterday. The evil force may delay our ascending temporarily, the upsurging trend has been carved in stone.

Tuesday gap up!

Nobody will be in a rash to present "failed" results. It's no coincident that Linda Powers pulled the trigger to buy Flaskwork, and Linda Liau (PI of the trial) and Bosch (CTO of the company) will both present in the Plenary Session on the trial results, making it ready in the last minutes submitting a late breaking abstract on 1 September.

Since then we see price has been rise substantially as the market started to smell something positive.

Remember what Linda said in a previous update: After the company is unblinded, the company would consult with PI, committees of experts for comments, and will determine the venue and time to present detail trial results.

Smart forces are buying while shorts are scrambling. At the time being the market still seems orderly except today's unexplained sudden drop from 0.60s to 0.05

That orderly market reaction will not last long as the general market comes to know what is really happening.

Gap up Tuesday!

Just submitted mine.

Get the dry powder ready for any unexpected and unwarranted drop of price.

And continually average up if possible

A huge gap up Tuesday!

Pity of those "smart" ones who sold for a penny or two profit

the smartest ones make some money while the dumbest ones lose money all the time. The one who make real money are those who can sense change and consensus.

Watch late this afternoon how the naked short wolfpack are scrambling to cover, and if they are they are lucky as the general market has not yet been ticked with headline of positive Topline data

For the dumbest ones, they are aiming to cover in dollars land.

But remember many long suffering longs are competing with each share available at this low price too

So are increased numbers of new investors

The old tricks of the short may not work beginning from today!

Not traders as you said. It's obviously the short (the wolfpack naked short) who sense an opportunity at close to the end of market at a hugely down day for the three big indexes.

The wolfpack are actually covering shares all day today and yesterday in almost all time. Then today they sensed the opportunity of big market down day and investors who have been buying too probably left at the time when the market was close to end.

They could just sell some shares at lower price, and waited; if there were buyers come right away willing to buy shares at or above the price they just sold, the short would know time was not right. But today seemed after the short tested sell, no serious buyers came.

So they were able to pain the floor at lower price for today so they hoped tomorrow they can continue their orderly covering at lower price.

It never changes that shorts are the most snaky ones on the market, but they can only get away when the market condition is not in our favor.

Now I think the market condition is actually in our favor. Who knows Linda would not drop another or two unexpected news at any time on top of expected Topline day announcement after Labor Day.

Technically and practically statisticians can know the general results almost right away after data lock, from a few hours to a day!

Nobody knows whether the database has been locked, and nobody knows whether Linda has had a peek at the results.

Too many unknowns and speculations at this stage all are in favor for higher share price.

One more million the "selling for profit" should be taken care of

We are heading higher from that

Big Pharms want a piece of it if not the whole. They have the right brains who see the huge potential of this revolutionary cancer fighting vehicle called DCVax, not only DCVax-L

They are onboard start competing shares with the shorts

Next, the general market will be wakened up

More shares will be grabbed and held

Shorts will have no way out who can only buy in the open market

Squeeze or not, they will be burned badly and they deserve it!

Short covering is just beginning, volume is higher than before but still not higher enough (forget that 12 million reg short, there are much much more the so-called naked shorts)

That's actually not all. It's just beginning!

Not all pharmas which want to buy nwbo can be assured in its acquisition or which want to be part of can be assured to be part of it. There are ways to offset those deficiencies

One way is to buy the stock of the said company either directly or indirectly, but mostly via an existing financial vehicle in the Wall Street.

Then you have all this awakening, chattering, etc about this company suddenly rising from nowhere for most potential investors as price and volume continue spike

Even purely technical an interesting story is unfolding!

So Flipper what he is if not short, or one working for naked wolfpack since he has been working hard for 24/7 for years after tens of thousands of post in this tiny board?

Lots of people are living in alternative world these days! Like no shorts, no naked shorts from the same persons who are part of it.

You must know I almost never reply to those people, let alone those in the lower ladder of the wolfpack. It's a wast of time and useless!

CDEL has given him a break. He will be back soon after break posting in coordination with xxx, xxxx, xxxx, and you know who they are

CDEL has been acting as lead of the wolfpack recently

I said this on 21 Aug: "Although I don't like it I expect naked short wolfpack will start to cover, there is simply no any other way out.

For all the vulture hedges collectively, you are as pathetic as the naked short wolpack." in the post: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=157793331

Now share price is up with significantly large volume compared to the past, indicating the short wolfpack is indeed covering, which I hated to see it's happening, more of preferring it happens when topline data is announced as I said multiple time in the past.

Well be happy things come this way!

Now as the wolfpack is covering in a still "orderly" manner, we only need some fuel in the already burning fire.

If only Linda's financiers either true friends of the company or those vultures can put some money in the working buying in the open market, that orderly manner will turn into what we have known as squeeze.

A $1 a share is in the reach very quickly before topline!

How could this trial (pivotal phase 3 DCVax-L for GBM) fail?

1) control arm outlives treatment arm? (very unlikely for GBM according to what have been known from literature and myriad of presentations from treating doctors);

2) No separation between control and treatment, and/or early and late (crossover) vaccinated patients? (very unlikely according to supposed mechanism of action of DCVax-L, and the suggestion of Dr. Linda Liau in her various presentations);

3) PFS messed up due to pseudo-progression? (may be true initially, but corrected after adjudication. More importantly, as the last patient in the trial lasts five years, PFS really doesn't matter anymore because it is just a surrogate for OS);

4) Treatment effects if any cannot be detected in a statistically significant way, ie, the p value being greater than 0.05? (may be likely due to crossover, but the efficacy can be backed up by comparing to similar external data and some immunogenetics data showing distinct immune-reactions before and after vaccination, etc.);

5) Not a pre-specified group or subgroup shows any statistically significant benefits? (very unlikely); and

6) All of the above or a combination of some of the above? (mostly unlikely)

A quick rough recap on what we have known today before unblinding:

1) mOS for all patients in the trial: about 23.1 months from surgery (compared to the standard of care: 14-17 months); and

2) One year mOS: 89.3 %; two year mOS: 46.4 %s; three year mOS: 28.2 % (based on 2018 updated data); and five year mOS: about 15-17% for all patients according to Les from his recent discussion (compared to standard of care which is about 5% at five years).

Conclusion: DCVax-L will be at least approved for treating GBM based on landmark long-term overall survivals (there are other ways for DCVax-L to get approved as well).

Feeling blessed and happy this morning, I also like to extend my kindness to the short wolfpack of which I has despised since its creation. Nonetheless they are human beings as well, maybe just got lost at an unfortunately time:

As of 19 August, all the trial data internal and external had been collected and datalock was pending on quality check and confirmation of only some external data currently acquired. [this is also Linda's creation, a new stuff for me as if nobody in the same condition never check quality LOL]

According to multiple news releases including the most recent one as of 19 Aug, it is expected to take a couple of weeks for statisticians to generate tables and curves, ie, data from locked database ready for topline data reporting.

As a matter of fact, anyone with brain knows that process can take a few hours or at best a couple of days to complete. [so seriously Linda what are you talking about?]

Seriously, someone may have already known what the unblinded data really looks like as of my typing now if data is already locked or someone may come to know the result a day or two after data is locked.

I find naked short wolfpack are numbed so are those who want to have a position before unblinding and results, which are both made to believe by the company they will not be available after TWO WEEKS OF STATISTICIAN WORKING ON IT, FOLLOWED BY TWO OR SEVERAL WEEKS OF CONSULTATION OF THE COMPANY WITH EXPERTS!

Don't know what is in Linda's mind with such timelines, but anything has a reason, so be it.

That's all Ladies and Gentlemen, short or long. Just watch. I guarantee it will be interesting to say the least. I like surprise particularly a very happy surprise!

Turn good news into "bad" news (damp any momentum by dumping a relatively large lot of shares into the market with lower price here or there opportunistically; because the so-called Linda friendlies are just a bunch of vulture hedges, like Bigger Capital, etc., they simply don't have either guts or resources to make the market, so the naked short wolfpack is easy to control and manipulate the market)

BTW, that's all Linda's choice for a bunch of small vulture hedges as her financiers because she can control them easily; I am afraid she doesn't like financiers like Neil or the Baker Brothers at this time because she may find it hard to control.

So at the time being, if the market reacts to any good news as it were a bad news, then the evidence is herewith in that the wolfpack is well and alive. They are still trapped, which will be extremely good for share price when a substantially good news comes out.

These pathetic wolfpack can only manipulate the market with a good news which is not substantially, and fundamentally earth-shaking like the ones we recently have within a month. So my prediction is that they will, even if not completely, unless they are retard

If they refuse to cover their butts, they are doomed.

Strong evidence naked short wolfpack is still on the hook and well and alive just as of today:

As usual, any good news led to lukewarm trading with pathetic volume as well. It has happened recently twice at least, as if Linda has no friend but foes who would do anything possible to dump her.

Unfortunately for naked short wolfpack, now it's a totally different ballgame: within a month or so, topline data will be revealed.

Based on what we have known, failure of the trial is nil.

Now I have to adjust my reserves on the day of burning short at much higher price.

Naked short wolfpack is just as stubborn as committed long. It will be a beautiful month or months to look forward to.

Although I don't like it I expect naked short wolfpack will start to cover, there is simply no any other way out.

For all the vulture hedges collectively, you are as pathetic as the naked short wolpack.

Added about 50k shares around 0.325

Short, knee jerking long and vulture hedges are collectively amazing

Stomp the apparent uptrend rooted from outright good news happened and in anticipation

LOL see you at the finish line in a month!

Made one half million dollar to add to the fire of short burning when topline data are announced

Bring on shorts, vulture hedges and knee jerking longs (I don't think you guys can hold for a week; maybe crack late today)

Enough money to get us into early next year with today's loan of $5.5 million on top of last weeks 8 million.

There will be no financing, further dilution for a long while

No more vulture hedges awaiting at Linda's door; if shares are wanted, please buy in the open market

Let's start counting the time until next news

Data lock

Topline data

Initiate a new trial

A partnership deal

Covid-19 therapeutic vaccine trial -- this one is a jock of course

Something unknown at this time

Slow blood bleeding finally stopped. Anyone needs to play fair in the open market. Selling or buying it's all your decision!

Looking in the mirror scotty.

[funny I realized I replied to you. It's a first]

Very sorry to hear that Sir Pumpernickel.

May God give you strength and healing power to your friend!

An unknown short hedge cohort winked at Dr. Boockvar. Dr.Bookckvar went off script during his planned presentation, adding DCVax-L "essential failed," contradicting his own script.

AVII was noticed, who suddenly showed up in IHub revealing the news after a long disappearance, and immediately went to dormant again.
As a result, more than 6 million shares traded with the share price about a few cents down from the previous trading. Taking the advantage, I brought my pools of shares to new higher.

Shortly complains were lodged on to almighty Doc, and he was more than willingly to agree to pull his presentation offline.

Nonetheless, damage has been done and the mission has been accomplished.

Be aware things like this has happed in the past and it will be repeating.

Notice it was AVII who first revealed temporary screen halt occurred in Germany via his short friend who posted in IV; it was AVII who first revealed Dr. LL's controversial presentation after the screen halt imposed by FDA; and it was also AVII who first brought this board's attention to Dr. Woockvar's now offline presentation. Are all these coincidences?

In biotech world, one should always keep vigilance and be prepared to take advantage of events like this, because it will not be the last!

Honestly the company has recently provided more information than most other companies of the same size under the same conditions.

Most companies would only say they have reached the events required for completing the trials, and give an approximate time for topline data announcement, which usually ranges from 2 months to several months.

They then usually raise substantially a large sum of cash, much larger than we have experienced with nwbo, and go dark/quiet until the announcement. And usually bad news comes much earlier than expected, and vice versa.

That's all.

Yes you are right on one thing that nwbo management has repeatedly moved the goal posts, which is disappointing to say the least but I think anything has a reason.

If you has done your dd, and committed to investing in this company, you ought to lay your trust on the management, unless you think their interests are not in line with yours.

We all want to see a successful trial results, and as of today the target time for that is still in September.

Why not exercising a bit more of patience, and prepared yourself for possible bear raid or not or a smooth sailing whatever it will come.

Most people are not heavily invested, they want the share price as low as possible so they can cover (for shorts), start new positions, add substantially more shares, etc.

But the nwbo tree is hard to be shake, because of the fact of the known blinded data, unless the placebo or the standard of care arms outlive the historical standard of care patients in a large margin, or the treatment arms. For other cancer indications, it's likely or even very likely but for GBM it seems unlikely based on what we have known.

you said, "If I was long I would tell LP she needs to gag him. He does a better job than I do for the 'pack smile,"

You know I seldomly reply to posters like you but one or two exceptions sometimes make no harm.

Now my opinion: I think Les has been doing an excellent job by appearing in such "a low-end clown" radio show by conveying one simple data set that the top 100 patients have mOS about 5 years, and one or two side/"new" information.

Why that is so important because after the publication of blinded data only one updated blinded data was presented subsequently with increased survival data trend (well two points I should not say that is a trend, at least a trend needs three points)

Since then we have had no new update, even not a simple statement like such that indicates how many patients still live at a future specific time -- that makes me a bit unease in terms of my large existing investment and my intention to buy more.

So it's a big relief Les said/confirmed that top 100 patients had mOS about 5 years on 24 July, and then again last Friday.

As a result of his 24 July show, I have increased my position several times.

Investors regardless how committed need some fundamental insurance, either it's how top 100 perform or something else depending on individuals. It's the broken of information flow or "a substantially long quiet period" that make this investment journey tough, as least for me, and it's exactly the time when posters like you who can work the most effective to discourage investment.

So I very much appreciate what Les has said and I think he has been doing favor for our long-term investors, only whom can understand what exactly he has been saying.

Linda has a plan. In about a month, she will appear in national stage. Russ and Sully are lucky to have Les as of now.

You are absolutely right for one thing that he indeed does a better job than you do for the naked short "wolfpack."

[btw ex that 85% and 25% are not completely independent, they can overlap]

Glad Flipper you have detected the transformation of Smith over the years into a willing lapdog for big Ps. There are obvious tracks left with his each click on his keyboard.

Besides he is prepared the mass to be ready for a pathetic $1 initial stock price when the trial data is deemed successful, which is exactly what the wolfpack have instilled in message board for years.

Let that price be true I will get in huge willing to borrow money from banks to get in it really huge despite I will be rich enough even without buying one share more at that time.

He eventually gives up and give in. Life must be really tough for him.

MartyDg I think my statement is quite clear that I did think there is no delay or a significant delay, ie, DL happened, and we are in a quiet period waiting for topline data, otherwise, we should have had an update by now explaining why DL is delayed, because two long weeks have passed the date of their last estimate for data lock, which is around early July.

Shorts usually take advantage of uncertainty, some of it genuine and some of it they create, like the usual IDs working hard in this board. During a quiet period, speculation goes wild and rampant, making it an optimal time for shorts to manipulate, inject FUD, and lower share price without much resistance, since there are always also knee jerking longs selling along with shorts short selling manipulation.

Nothing has changed except it gets closer to topline data announcement.

For any shares sold, there are their buyer. Like many, I added shares, and prepared for adding more, particularly if such conditions happen when positive topline data is published, like share price below $2 with positive data.

It's always good to have some dry powder ready for situation like such.

It's coming. GL

[Again English comprehension: "notify all at the same time" means notify all investors or any ones who concern in one press release or SEC filing or any public form of notification -- so it will be at the same time anybody knows what happens, so the company will not face any potential lawsuit accusing them of giving preferential information to some while holding the same information from others. It's a common practice for any public traded company in dealing with such issues]

English comprehension, anders, refer to my previous post which explains what his words convey.

It's a perfect English, I don't know why it gets confused.

[done my posts today, GL]

If it is delayed, they will update. Yes, since it has not been delayed, why should they update us, let alone a significant delay?

Almost three weeks passed the day they said DL should happen, which in any definition is a significant delay, and the fact they have not updated us indicates IT IS NOT DELAYED, AND IT HAPPENED AS PLANNED.

NEXT TOPLINE NEWS

LET SHORTS BE EMBOLDENED

THAT WE CAN BUY SHARES CHEAP

AND THAT WE CAN BURY THEM DEEPER WHEN THE TIME COMES!

Dave's response to one poster in this board:

Quote:

I am not sure why this is an issue. We have said for a long while that we will notify all at the same time when we have reached lock.

Hope that helps

Dave

end of Quote

I don't know why some here feel confused with regards to DL from Dave's response. From his response he clearly indicate the company will notify when DL WAS reached. It was completed, and he didn't promise the company would notify as soon as it happened.

So one way to notify us is a paragraph or a footnote in topline data news release, just mentioned when data lock had had happened.

As I have said all along it [DL] did happen, and next may indeed topline news.

WE ARE IN THE QUIET PERIOD! Buy shares as much as you can afford.

My last post for today: it's useless to debate/discuss what and how the company has said/promised and what the company should have done or should do regarding data lock. It's useless to confuse selves with various forms of data lock, even as the company has suggested/caused it, including soft lock, initial lock and hard lock.

The most important thing now is that the company will definitely doing its job to acquire topline data and the company will announces it shortly.

Give Linda a wiggle room. She may need it and it will be definitely doing our good in the end.

Trust me. Take a break if you are not going to buy more, and let the shorts be emboldened because they will pay dearly shortly.

Good luck to all!

My only recommendation to longs if I may is that one should have drawn a line where a successful trial is clearly marked with data:

My line to put it simple is this: judged by risk/benefit ratio the FDA ponders when it makes decision on approve or not approve a drug or a biological agent or something in between, DCVax-L trial will be successful as long as there is demonstrated separations between either of the standard care arm and the treatment arm, the early and later vaccined arms, the intended to treat patients and comparable historical standard care data (as FDA's recent guideline suggests), specified patient groups with clearly specified biomarks as we already know DCVax-L is safe.

Nobody should or dare to decline to approval a vaccine which is SAFE and somewhat effective, having a good quality of life indication, and tailored for self treatment from one's own cell, let alone I strongly believe DCVax-L trial will show strong treatment effects.

so that to draw another line of trading/investment/buy or sell when topline data is announced: a line marked by reasonable market cap, either it is 3 billions or 20 billions, a line where below it it's time to buy regardless what the share price will be and believe it will be temporary, and the market will live to its law to reflect a rational and reasonable share price (market cap to be exact).

The shorts have put our lives in misery for so long and more importantly have potentially harm so many patients on their track of destruction, when the time comes, we ought to grab/compete away as many as possible shares from the terrified shorts mouths, and let them pay.

Now I am going to buy again as the board turned negative for a couple of days when longs are just waiting for something news worthy to release from the company.

All the usual wolfpack IDs became active in recent days, including the pathetic last Sunday when the usual identifiable IDs were hard in working in message board. It's a sign.

Now that Linda has shown her hand -- the multiple self-rewarded Form 4s for their hardworking of the last several years while stock price has been manipulated by short sell, and the market cap now sit at the low 250 million level.

When Linda finally showed her hand, it means the trial data is destined to be locked, and topline comes shortly in a couple of weeks if not less.

I believe the blended data today is at least as good as that we saw in 2017 and again in 2018; the likelihood of the placebo/later vaccined arm outperforms the treatment/the early vaccined arm is low based on what we have known about the disease GBM and the various failed trials and the Optune trial, etc.

Today's buying is a knowledge based risk taking mini exercise, ready for significant grabbing shares from the shorts when topline data is announced. I am pretty sure this scenario will happen as the price will still be very much suppressed then judged by some longs' knee jerking actions and too many swing traders waiting on the sideline.

Now it's action time.

[Lawyers are good when it comes to eventuality for a company. Linda and Les maybe despised for their failure to maintain/support a reasonable share price, but when all things are done, they will be much more worthy in share price, either at buyout or partnership!]

[And they will be remembered by their resolve/dexterity/"deception" to bring a "failed" trial into a hugely successful trial. No other non-lawyers run companies will success in our situations!]

[One more buying sign: the share flipping has stopped from option/warrant holders]

All signs and feels and indications point to the empirical fact that we are currently in the quiet period, forget whether the trial has been soft or hard locked, meaning the next announcement will well be topline data.

Yet the stock behaves like we are waiting for some kind of data lock and then a few more weeks of time until topline data are ready for announcement.

Shorts are successfully fooling some long investors, and importantly themselves.

Low volume and range bound trading around $0.35.

The big battle ahead after topline data announcement is what should be the support for the long suppressed stock price.

Shorts like it to be one or two bucks, while longs want it to be much much higher.

I believe Les and Dave have been working on this front frantically for some time now, and we will be seeing if they are competent.

I have funds ready to get more and big when it happens.

Since the announcement that the company is proceeding with data lock, etc.

Read carefully or you just waste my post to reply.

BTW to anyone who read this board, it's a dream to wait if you want to get additional shares or start a new position hoping the price will drop from here in the 0.35-0.36 range.

The reason is simple, 1) topline is ahead, a week or a month or two doesn't matter, and 2) we are cheap at a market cap of around 250 million

BTW2, as I have said previously, I would like Linda to surprise the market

It is supposed to be that we are in a quiet period if we are an average small biotech approaching a binary event -- a pivotal phase 3 trial revelation of topline data.

Usually, a company would announce it has reached the threshold, either a required event count or some other pre-specified cutoff rate/ratio/number, then the company would normally have a significant fund raise with a friendly backer, cause nobody would be assure the outcome, and better be prepared for either any possible unpleasant outcome or positive outcome with money on hand, for flexibility in either direction heading towards collapse or FDA approval. After the fund raise, the company would go dark until topline, which ranging from two months to several months (usually three months maximal actually).

Judged by the practice of an average company, we are deep into the quiet period. Regardless whether the company has promised to announce data lock or not, really we are now in the deep quiet period. Unless the company wants to raise fund with the help of data lock announcement, we should hear nothing until topline data.

Any days pass by without news is a good news. It's positive we have not had a significant fund raise yet, and it's positive we have not heard of any other trials, as either backing or distraction -- a common practice of an average small biotech facing such a binary event.

So let's count days that have passed as of today.

I am heading in that direction Sojourner. thanks. Except just don't want to do fasting yet. All seem good at the present. Can easily swim 2 -3 miles, and play tennis games 2 ~ 3 hours non-stop.

Enjoying walking and hiking but need to increase intensity.

Look forward to the weeks ahead.

Thanks flipper for your recommendation and personal experience.

Already practiced these in principle for over a year with less intensity though than recommended: probably only 3,000 to 6,000 steps a day, heavy swimming two or three times a week, occasional weightlifting, hiking, etc.

My blood pressure dropped, but weight remains in an undesirable level after an initial drop somewhat. Don't want to punish myself for not eating delicious foods, particularly meat with some fat. So it's no dieting for me except consuming less amount. That explain it's hard for me to chop a few more pound, which I accept at the time being, unless I increase exercising intensity and/or go on a diet.

My experience/observation of myself that drinking helps gaining weight, particularly in the waist, seems contrary to popular belief.

Maybe people are really different on this matter.